Bleakley Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-825
| Closed | -$224K | – | 1022 |
|
|
2024
Q1 | $224K | Buy |
+825
| New | +$224K | 0.01% | 851 |
|
|
2023
Q3 | – | Sell |
-1,012
| Closed | -$213K | – | 899 |
|
|
2023
Q2 | $213K | Sell |
1,012
-37
| -4% | -$7.78K | 0.01% | 827 |
|
|
2023
Q1 | $212K | Sell |
1,049
-280
| -21% | -$56.5K | 0.01% | 810 |
|
|
2022
Q4 | $290K | Buy |
+1,329
| New | +$290K | 0.01% | 710 |
|